<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0067-8103-50
</NDCCode>
<PackageDescription>
1 BOTTLE in 1 CARTON (0067-8103-50) > 50 TABLET, FILM COATED in 1 BOTTLE
</PackageDescription>
<NDC11Code>
00067-8103-50
</NDC11Code>
<ProductNDC>
0067-8103
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Excedrin
</ProprietaryName>
<ProprietaryNameSuffix>
Migraine
</ProprietaryNameSuffix>
<NonProprietaryName>
Acetaminophen, Aspirin (nsaid) And Caffeine
</NonProprietaryName>
<DosageFormName>
TABLET, FILM COATED
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20121022
</StartMarketingDate>
<EndMarketingDate>
20180307
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA075794
</ApplicationNumber>
<LabelerName>
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
</LabelerName>
<SubstanceName>
ACETAMINOPHEN; ASPIRIN; CAFFEINE
</SubstanceName>
<StrengthNumber>
250; 250; 65
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1; mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-03-07
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20141113
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20180307
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>